Presentation is loading. Please wait.

Presentation is loading. Please wait.

Transapical Aortic Valve Replacement for Severe Aortic Stenosis: Results From the Nonrandomized Continued Access Cohort of the PARTNER Trial  Todd M.

Similar presentations


Presentation on theme: "Transapical Aortic Valve Replacement for Severe Aortic Stenosis: Results From the Nonrandomized Continued Access Cohort of the PARTNER Trial  Todd M."— Presentation transcript:

1 Transapical Aortic Valve Replacement for Severe Aortic Stenosis: Results From the Nonrandomized Continued Access Cohort of the PARTNER Trial  Todd M. Dewey, MD, Bruce Bowers, MD, Vinod H. Thourani, MD, Vasilis Babaliaros, MD, Craig R. Smith, MD, Martin B. Leon, MD, Lars G. Svensson, MD, PhD, E. Murat Tuzcu, MD, D. Craig Miller, MD, Paul S. Teirstein, MD, Jeffrey Tyner, MD, David L. Brown, MD, Gregory P. Fontana, MD, Raj R. Makkar, MD, Mathew R. Williams, MD, Isaac George, MD, Ajay J. Kirtane, MD, MS, Joseph E. Bavaria, MD, Michael J. Mack, MD  The Annals of Thoracic Surgery  Volume 96, Issue 6, Pages (December 2013) DOI: /j.athoracsur Copyright © 2013 The Society of Thoracic Surgeons Terms and Conditions

2 Fig 1 Kaplan-Meier time-to-event curves for all-cause mortality. (AVR = aortic valve replacement; NRCA-TA = nonrandomized continued access transapical transcatheter aortic valve replacement; PMA-TA = premarket approval transapical transcatheter aortic valve replacement.) The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2013 The Society of Thoracic Surgeons Terms and Conditions

3 Fig 2 Kaplan-Meier time-to-event curves for stroke. (AVR = aortic valve replacement; NRCA-TA = nonrandomized continued access transapical transcatheter aortic valve replacement; PMA-TA = premarket approval transapical transcatheter aortic valve replacement.) The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2013 The Society of Thoracic Surgeons Terms and Conditions

4 Fig 3 Kaplan-Meier time-to-event curves for the composite end point of all-cause mortality or stroke. (AVR = aortic valve replacement; NRCA-TA = nonrandomized continued access transapical transcatheter aortic valve replacement; PMA-TA = premarket approval transapical transcatheter aortic valve replacement.) The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2013 The Society of Thoracic Surgeons Terms and Conditions

5 Fig 4 New York Heart Association functional status among survivors. (AVR = aortic valve replacement; NRCA-TA = nonrandomized continued access transapical transcatheter aortic valve replacement; PMA-TA = premarket approval transapical transcatheter aortic valve replacement.) The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2013 The Society of Thoracic Surgeons Terms and Conditions


Download ppt "Transapical Aortic Valve Replacement for Severe Aortic Stenosis: Results From the Nonrandomized Continued Access Cohort of the PARTNER Trial  Todd M."

Similar presentations


Ads by Google